Fri.Jul 05, 2024

article thumbnail

NeuroSense Therapeutics shares positive results of lead candidate in ALS

PharmaTimes

The neurodegenerative disease currently affects more than 200,000 people worldwide

Leads 120
article thumbnail

Why Wait? The Urgency of Accessible PTSD Treatments Now

MedCity News

In our eagerness for innovation, there’s a risk that we ignore existing effective, readily-available treatments. The post Why Wait? The Urgency of Accessible PTSD Treatments Now appeared first on MedCity News.

118
118
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study reveals mobile phone data can help map the spread of pathogens

PharmaTimes

Pneumococcus is the leading cause of pneumonia, meningitis and sepsis worldwide

Leads 111
article thumbnail

Private equity firms ‘eyeing $20bn for Sanofi consumer unit’

pharmaphorum

Reports indicate that private equity firms Bain Capital and Cinven may be contemplating a bid for the consumer health division of Sanofi.

110
110
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

True Blue-Dot Navigation in Healthcare is Both Harder and More Important Than You Think

MedCity News

When someone is sick or worried about an ailing loved one, they are already under stress. A good digital wayfinding experience can reduce that strain. The post True Blue-Dot Navigation in Healthcare is Both Harder and More Important Than You Think appeared first on MedCity News.

article thumbnail

NHS will take more than one term to fix, says Streeting

pharmaphorum

After Labour landslide in UK general election, former shadow health secretary West Streeting sets out his objectives for the NHS.

105
105

More Trending

article thumbnail

Pharma responds to 2024 UK General Election

European Pharmaceutical Review

Following the Labour Party’s win yesterday in the UK 2024 General Election, industry representatives have voiced their opinions on what this could mean for the future of the pharmaceutical industry under the new government. Association of the British Pharmaceutical Industry (ABPI) The new government now needs to hit the ground running and rapidly set out a clear, detailed plan” “During its campaign, Labour was right to single out the UK’s life sciences sector as a critical partner fo

Pharma 98
article thumbnail

Innovent sells its share in CAR T-cell therapy to IASO Bio for 18% equity

Pharmaceutical Technology

Fucaso, a BCMA CAR T-cell therapy, is co-developed by Innovent and IASO Bio and was approved to treat multiple myeloma in China last month.

97
article thumbnail

Improving the Efficacy of Genetic Medicines

PharmaTech

Shawn Davis, CEO of Liberate Bio, shares some insights into the world of drug discovery, development, and delivery, as well as process optimization

article thumbnail

Meet Our Mentor: Scott Nelson

MedTechVets

JUL 6TH – We were proud to interview MedTechVet Traing Program Mentor, Scott Nelson. Scott is currently the Marketing Strategist for Wound Management and Surgical Reconstruction at LifeNet Health. Veterans have so much to offer but often limit their self-promotion which makes entering an entirely new industry very difficult. Our med tech space would benefit so much from these transitioning members that have incredible skills and experience.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

BioSenic to extend US patent for ATO use in sepsis treatment

Pharmaceutical Technology

BioSenic and Medsenic filed patent application with the USPTO to extend the protection for the use of arsenic trioxide (ATO) for sepsis.

59
article thumbnail

Advancing Analytical Testing Techniques

PharmaTech

Although advancements in analytical drug substance testing are being made, the increasing diversity of the therapeutic landscape is necessitating further innovation.

53
article thumbnail

UK life science industry optimistically embraces Labour victory

Pharmaceutical Technology

The UK life science industry is crossing its fingers as a Labour government takes the reigns following 14 years of Conservative rule.

article thumbnail

Comparing Bariatric Metabolic Surgery, Glucagon-Like Peptide-1 Receptor Agonists Mortality Among Patients with Obesity and Diabetes

Pharmaceutical Commerce

An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

EAN 2024: sublingual apomorphine better tolerated by dopamine agonist users

Pharmaceutical Technology

SL-APO is marketed by Bial in France, Germany, Spain and the UK for the on-demand treatment of leveodopa wear-off.

article thumbnail

Pharma Pulse 7/5/24: Annual Life Sciences Good Manufacturing Practices Master Class 2024, FDA Grants Marketing Authorization for Rapid Hep C Test

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 52
article thumbnail

EMA validates Philogen and Sun Pharma’s MAA for melanoma

Pharmaceutical Technology

The EMA has validated Philogen and Sun Pharmaceutical’s marketing authorisation application (MAA) for Nidlegy, a treatment for melanoma.

article thumbnail

Pharma Pulse 7/5/24: The Impact of FDA's Diversity Action Plan, Apple Poised to Get OpenAI Board Observer Role & more

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

How will a Labour government support the UK clinical trials industry?

Pharmaceutical Technology

The UK took to the polls on 4 July 2024 and voted in a new government. How will a Labour government look for the clinical trial sector?

article thumbnail

Femasys Founder Discusses Femaseed Technology Designed to Support Infertility

PharmExec

In an interview with Pharm Exec Associate Editor Don Tracy, Kathy Lee-Sepsick, Founder, CEO, Femasys, offers a description of how Femaseed works to support women who struggle with infertility.

52
article thumbnail

Dupixent “addresses current gap” in COPD biologics landscape

Pharmaceutical Technology

Whilst Regeneron and Sanofi secured approval in Europe for COPD, the FDA has delayed Dupixent’s application review for the disease in the US.

FDA 52
article thumbnail

Study: Vitamin D Could Alleviate Negative Impacts of Monosodium Glutamate

Pharmacy Times

Vitamin D could mitigate negative impacts on neurobehavior and weight gain caused by consumption of monosodium glutamate (MSG).

42
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

New Labour government backs pharma reform in UK

Pharmaceutical Technology

As the UK transitions into a Labour party government, the pharma industry urges for boosted investment and talent attraction.

article thumbnail

Pharmacists Enhance Patient Care Through Medication Titration and Lifestyle Support

Pharmacy Times

Pharmacists can play a crucial role in diabetes management by implementing standing order protocols for medication titration and serving as a bridge between patients and other health care providers.

Medical 37
article thumbnail

CAN-3110 by Candel Therapeutics for High-Grade Glioma: Likelihood of Approval

Pharmaceutical Technology

CAN-3110 is under clinical development by Candel Therapeutics and currently in Phase I for High-Grade Glioma.

45
article thumbnail

Common Adverse Reactions to EGFR Therapy

Pharmacy Times

Alan Chin, PharmD, BCOP, presents an overview of the most prevalent and common adverse reactions associated with EGFR-targeted therapies in metastatic NSCLC and shares strategies to mitigate toxicities, with a focus on managing dermatologic events such as rash and itching.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

CTX-310 by CRISPR Therapeutics for Hypertriglyceridemia: Likelihood of Approval

Pharmaceutical Technology

CTX-310 is under clinical development by CRISPR Therapeutics and currently in Phase II for Hypertriglyceridemia.

40
article thumbnail

Expert Insights on Managing Amivantamab Infusion Reactions, Dosing, and Medication

Pharmacy Times

A pharmacy expert explores infusion-related reactions associated with amivantamab, providing guidance on managing and preventing these reactions, while also addressing the role of split-dosing, premedications, and steroids in the treatment paradigm.

article thumbnail

CTX-310 by CRISPR Therapeutics for Heterozygous familial hypercholesterolemia (heFH): Likelihood of Approval

Pharmaceutical Technology

CTX-310 is under clinical development by CRISPR Therapeutics and currently in Phase II for Heterozygous familial hypercholesterolemia (heFH).

40
article thumbnail

Dupilumab Helps Pediatric Patients With Eosinophilic Esophagitis Achieve Histologic Remission

Pharmacy Times

In 2 different dose groups, the majority of patients with eosinophilic esophagitis aged 1 to 11 achieved histologic remission at week 16 compared with patients treated with placebo.

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A